Ticker Hub
DTIL — AI Analysis & Sentiment
3 recent AI-generated analyses for DTIL. Sentiment and confidence insights updated continuously.
iECURE Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of ECUR-506 Ahead of Planned BLA Submission
The FDA's selection of iECURE's ECUR-506 into a development program is a significant positive for Precision BioSciences, validating its ARCUS platf...
Mar 18, 2026Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
Two U.S. patent allowances for Precision BioSciences' key PBGENE-HBV program significantly strengthen its intellectual property and future revenue ...
Mar 11, 2026Precision BioSciences Presents Preclinical PBGENE-DMD Data Highlighting Durable Dystrophin Expression and Functional Benefit at the Muscular Dystrophy Association Clinical & Scientific Conference 2026
Strong preclinical data for PBGENE-DMD de-risks Precision BioSciences' lead gene editing candidate for Duchenne muscular dystrophy. This boosts con...
Mar 10, 2026